RankingsPricing
  1. US-listed companies
  2. MEDICINOVA INC
  3. Financials
  4. Cash from operations

MEDICINOVA INCMNOV

Market cap
$72.1M
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2024-11+43.22%
Dec 31, 2023-7-42.45%
Dec 31, 2022-13+37.63%
Dec 31, 2021-9-13.34%
Dec 31, 2020-11+18.65%
Dec 31, 2019-9+0.12%
Dec 31, 2018-9+31.63%
Dec 31, 2017-7+5.77%
Dec 31, 2016-7-8.47%
Dec 31, 2015-7-975.95%
Dec 31, 20141-107.67%
Dec 31, 2013-11-10.27%
Dec 31, 2012-12-10.85%
Dec 31, 2011-13

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)